Participant enrollment to start in early 2014
Two new clinical trials funded largely by NIA—a major Alzheimer’s
prevention study and a test of a promising insulin therapy in people
with mild cognitive impairment or mild Alzheimer’s disease—are set to
begin recruiting participants in early 2014.
The much-anticipated trials are being conducted by the Alzheimer’s Disease Cooperative Study
(ADCS), an NIA-funded consortium of more than 76 research sites in the
United States and Canada, coordinated by the University of California,
San Diego. The ADCS focuses on evaluating interventions that will
benefit Alzheimer’s patients across the disease spectrum.
